However, information on clinicopathological factors seemed insufficient to draw any conclusions; approximately half the data on tumour grade, disease stage, and lymph node metastasis were not identified, and the researchers did not mention the prognosis of patients with p-Stat3 immunoexpression. This evidence concerns the gene STAT3 and metastatic malignant neoplasm in the lymph nodes.